3 completed, 2 recruiting, 2 unknown. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Recruiting 2, Unknown 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Chemoradiation: new trials by email Literature Review of Chemoradiation trials Research Report on Chemoradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC neoadjuvant chemoradiation - Esophageal Squamous Cell Carcinoma, Chemoradiation | Phase 2 / Phase 3 | Unknown | National Taiwan University Hospital | 248 | 2017-03-01 | 2022-06-07 |
| PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy Tegafur-Gimeracil-Oteracil Potassium, Chemoradiotherapy, Gastric resection - Stomach Neoplasm, GastroEsophageal Cancer | Phase 3 | Completed | Shanghai Cancer Hospital, China | 204 | 2016-12-01 | 2025-12-08 |
| Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 SIB-IMRT, S-1 - Esophagus Cancer, Esophagogastric Junction Cancer | Phase 2 / Phase 3 | Completed | Chinese Academy of Medical Sciences | 350 | 2016-10-01 | 2020-07-21 |
| S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer Radiotherapy 54 Gy, Radiotherapy 60 Gy, S-1 - Esophageal Cancer, Chemoradiation | Phase 3 | Completed | Zhejiang Cancer Hospital | 298 | 2016-06-01 | 2020-09-16 |
| Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma PF (cisplatin and 5-fluorouracil) group, TPF (docetaxel plus cisplatin and 5-fluorouracil) group - Chemoradiation, Nasopharyngeal Carcinoma | Phase 3 | Unknown | Zhejiang Cancer Hospital | 400 | 2012-04-01 | 2013-03-05 |
| Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer Radiotherapy, Platinum based chemotherapy, Paclitaxel based chemotherapy - Esophagus Cancer, Esophagogastric Junction Cancer | Phase 3 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2000 | 2002-01-01 | 2026-01-21 |
| Neoadjuvant Treatment Modalities in Esophageal Cancer Platinum based chemotherapy, Paclitaxel based chemotherapy, Radiotherpay - Esophageal Cancer, Chemotherapy Effect | Phase 3 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2000 | 2002-01-01 | 2026-01-21 |
Esophageal Neoplasms (4) · Adenocarcinoma (1) · Esophageal Squamous Cell Carcinoma (1) · Nasopharyngeal Carcinoma (1) · Stomach Neoplasms (1)
Neoplasms (7) · Neoplasms by Site (7) · Digestive System Diseases (6) · Digestive System Neoplasms (6) · Gastrointestinal Diseases (6) · Gastrointestinal Neoplasms (6) · Head and Neck Neoplasms (6) · Esophageal Diseases (5) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Carcinoma, Squamous Cell (1) · Esophageal Neoplasms (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1)
S 1 (combination) (3) · Immunotherapy (2) · Platinum Compounds (2) · nimotuzumab (2) · Chemoradiotherapy (1) · Cisplatin (1) · Docetaxel (1) · Esophagectomy (1) · Fluorouracil (1) · Gastrectomy (1) · Neoadjuvant Therapy (1) · Oxaliplatin (1) · Population Groups (1) · Radiotherapy (1) · Surgical Procedures, Operative (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2) · Zhejiang Cancer Hospital (2) · Chinese Academy of Medical Sciences (1) · National Taiwan University Hospital (1) · Shanghai Cancer Hospital, China (1)
China (6) · Taiwan (1)
Xiaozhong Chen, MD (1) · Ya-nong Wang, M.D. (1) · Zhen Zhang, M.D. (1)
PMID 30373600, PMID 30797141, PMID 31036088, PMID 31221115, PMID 32983991, PMID 34351356, PMID 37195667, PMID 40340830, PMID 40367097, PMID 41893843